Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 4/20 | 0.63 |
| ▸ | PTPN7 | P35236 | 3/20 | 0.63 |
| ▸ | PTPN12 | Q05209 | 3/20 | 0.63 |
| ▸ | PTPN22 | Q9Y2R2 | 3/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.62 |
| ▸ | MEN1 | O00255 | 8/20 | 0.62 |
| ▸ | POLB | P06746 | 4/20 | 0.62 |
| ▸ | CTDSP1 | Q9GZU7 | 2/20 | 0.62 |
| ▸ | BLM | P54132 | 1/20 | 0.62 |
| ▸ | DDX3X | O00571 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.56 |
| ▸ | MMP2 | P08253 | 1/20 | 0.56 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | CASP3 | P42574 | 1/20 | 0.50 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.50 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.50 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12008591 | 0.89 | PTPN12 (0.80) | GPR35PTPN7PTPN12PTPN22KMT2A | |
| SCHEMBL12008620 | 0.84 | GPR35 (0.88) | GPR35PTPN7PTPN12PTPN22KMT2A | |
| SCHEMBL12008765 | 0.82 | PTPN12 (0.91) | GPR35PTPN7PTPN12PTPN22KMT2A | |
| SCHEMBL6720199 | 0.78 | MEN1 (0.85) | GPR35PTPN7PTPN12PTPN22KMT2A | |
| SCHEMBL12008735 | 0.77 | PTPN12 (1.00) | GPR35PTPN7PTPN12PTPN22KMT2A | |
| SCHEMBL18539157 | 0.77 | KMT2A (0.84) | GPR35PTPN7PTPN12PTPN22KMT2A | |
| SCHEMBL18539158 | 0.76 | DDX3X (0.84) | GPR35PTPN7PTPN12PTPN22KMT2A | |
| SCHEMBL12008593 | 0.76 | KMT2A (1.00) | GPR35PTPN7PTPN12PTPN22KMT2A | |
| SCHEMBL18545482 | 0.75 | PTPN12 (0.65) | GPR35PTPN7PTPN12PTPN22KMT2A | |
| SCHEMBL12008590 | 0.74 | KMT2A (1.00) | GPR35PTPN7PTPN12PTPN22KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170049751-A1 | OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF | DASGUPTA RAMANUJ (US) | 2017-02-23 | — | — | US | disclosed |
| US-20170049751-A1 | OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF | DASGUPTA RAMANUJ (US) | 2017-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170049751-A1 | OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF | CTNNB1, CTNNA1, CTNNBL1 | GPR35 299/4885PTPN7 190/4885PTPN12 457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.